Surgeons attended a satellite lunch symposium sponsored by Somahlution, Medistim and VGS to learn more about new technologies (including DuraGraft) to reduce vein graft failure and improve clinical outcomes following CABG surgeries. The session was moderated by Professor David Taggart and included speaker Dr. John R. Pepper, who spoke about the clinical need for DuraGraft and its effect on Vein Graft Failure (VGF) rates.
DuraGraft is a first-in-class product intended for the preservation, storage and flushing of vascular grafts in both coronary artery and peripheral bypass surgeries to reduce the burden of Vein Graft Disease and subsequent Vein Graft Failure. Surgeons at the meeting learnt about damage caused by solutions that are used currently, and measures to protect the endothelium while preserving, storing and flushing arteries and veins intraoperatively during cardiac and peripheral vascular bypass surgeries. In addition, functional characteristics of DuraGraft and access to the product worldwide were discussed.
Surgeons were surprised to learn that by simply avoiding the use of standard of care graft storage solutions such as saline and autologous blood and opting to use DuraGraft instead, clinical outcomes could be significantly improved*.
To view the portion of the Satellite Symposium featuring Dr. John R. Pepper.
If you are unable to view Dr. Pepper’s video on YouTube, please click here.
*Thatte, HS,; Biswas, KS,; Najjar, SF,; Birjiniuk, V,; Crittenden, MD,; Michel, T,; Khuri, SK,; Multi-Photon Microscopic Evaluation of Saphenous Vein Endothelium and Its Preservation With a New Solution, GALA. Elsevier Science Inc. Annals of Thoracic Surgery 2003; 75:1145-1152.
Back to the latest news